Trial Profile
Vandetanib for advanced medullary thyroid cancer, in a real-life setting.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Vandetanib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2015 New trial record